headerdesktop mosnick18noi25

MAI SUNT 00:00:00:00

MAI SUNT

X

headermobile mosnick18noi25

MAI SUNT 00:00:00:00

MAI SUNT

X

Promotii popup img

🎁Târgul Ghetuțelor🎁

Cadouri de Moș Nicolae

-77%, -30%, -50%

Comandă aici!

Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine

De (autor): Alex Belser

Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine - Alex Belser

Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine

De (autor): Alex Belser

Belser, Alex: - Alex Belser is a psychologist and psychedelic researcher in clinical trials at NYU and Yale University. He is also the co-co-founder of the psychedelic research group at NYU. He studied at Georgetown University, the University of Cambridge, Columbia University, NYU, and Yale University. He is the Chief Clinical Officer of Cybin, and served as Chief Clinical Officer at Adelia Therapeutics. Additionally, he is a member of Chacruna Institute's Women, Gender Diversity, and Sexual Minorities Working Group. He has investigated psilocybin and MDMA to treat depression, anxiety, substance use, OCD, PTSD, and end-of-life distress. He is co-author of EMBARK, a psychedelic-assisted psychotherapy model, and was a contributor to Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture, (Synergetic Press, 2021).
Citește mai mult

-20%

PRP: 136.09 Lei

!

Acesta este Prețul Recomandat de Producător. Prețul de vânzare al produsului este afișat mai jos.

108.87Lei

108.87Lei

136.09 Lei

Primești 108 puncte

Important icon msg

Primești puncte de fidelitate după fiecare comandă! 100 puncte de fidelitate reprezintă 1 leu. Folosește-le la viitoarele achiziții!

Livrare in 2-4 saptamani

Descrierea produsului

Belser, Alex: - Alex Belser is a psychologist and psychedelic researcher in clinical trials at NYU and Yale University. He is also the co-co-founder of the psychedelic research group at NYU. He studied at Georgetown University, the University of Cambridge, Columbia University, NYU, and Yale University. He is the Chief Clinical Officer of Cybin, and served as Chief Clinical Officer at Adelia Therapeutics. Additionally, he is a member of Chacruna Institute's Women, Gender Diversity, and Sexual Minorities Working Group. He has investigated psilocybin and MDMA to treat depression, anxiety, substance use, OCD, PTSD, and end-of-life distress. He is co-author of EMBARK, a psychedelic-assisted psychotherapy model, and was a contributor to Psychedelic Justice: Toward a Diverse and Equitable Psychedelic Culture, (Synergetic Press, 2021).
Citește mai mult

S-ar putea să-ți placă și

De același autor

Părerea ta e inspirație pentru comunitatea Libris!

Istoricul tău de navigare

Acum se comandă

Noi suntem despre cărți, și la fel este și

Newsletter-ul nostru.

Abonează-te la veștile literare și primești un cupon de -10% pentru viitoarea ta comandă!

*Reducerea aplicată prin cupon nu se cumulează, ci se aplică reducerea cea mai mare.

Mă abonez image one
Mă abonez image one
Accessibility Logo